Group 1 (n=112) | Group 2 (n=388) | Total sample | Test value (p) | |||
Age | ||||||
Mean ± SD (years) | 56.54 ± 9.437 | 59.09 ± 9.686 | 57.53 ± 9.57 | p=0.08 | ||
Sex | ||||||
Male | 98 | 87.5% | 302 | 77.8% | 400 (80%) | p=0.11 |
Female | 14 | 12.5% | 86 | 22.2% | 100 (20%) | |
DM | ||||||
Insulin treated | 8 | 7.14% | 30 | 7.74% | 228 (45.6%) | *FEp=0.02 |
Orally treated | 28 | 25% | 162 | 41.7% | ||
HTN | 56 | 50% | 244 | 62.9% | 300 (60%) | p=0.08 |
Smoker | ||||||
Current smoker | 62 | 55.3% | 172 | 44.3% | 234 (46.8%) | * FEp =0.01 |
Former smoker | 18 | 16.1% | 30 | 7% | 48 (9.6%) | |
Dyslipidemia | 44 | 39.3% | 120 | 30.9% | 164 (32.8%) | p=0.24 |
CKD | 4 | 3.6% | 36 | 9.3% | 40 (8%) | p=0.262 |
FH of CAD | 24 | 21% | 70 | 18% | 94 (18.8%) | p=0.56 |
Hx of ACS | 4 | 3.6% | 32 | 8.2% | 36 (7.2%) | p=0.378 |
Hx of PCI | 8 | 7.1% | 56 | 14.4% | 64 (12.8%) | p=0.15 |
Group 1 (n=112) | Group 2 (n=388) | p | ||||
Admission to PCI | ||||||
Min.—Max. (h) | 12–72 | 12–72 | MWp = 0.35 | |||
Mean ± SD. (h) | 27.11 ± 10.651 | 28.73 ± 11.956 | ||||
Median (h) | 24 | 24 | ||||
Killip class | ||||||
I | 102 | 91.07% | 362 | 93.3% | MWp=0.77 | |
II | 6 | 5.4% | 18 | 4.6% | ||
III | 4 | 3.6% | 8 | 2.1% |